NCT00136565 - Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 8, 2006

Primary Completion Date

April 18, 2011

Study Completion Date

April 18, 2011

Conditions

Peripheral T-cell Lymphoma

Interventions

DRUG

Velcade

1.5 mg/m², D1, D5, 4 cycles

DRUG

Doxorubicin

75 mg/m², D1, 4 cycles

DRUG

Prednisone

60 mg/m², D1-D5, 4 cycles

DRUG

Cyclophosphamide

1200 mg/m², D1, 4 cycles

DRUG

Vindesine

2 mg/m², D1, D5, 4 cycles

DRUG

Bleomycin

10 mg, D1, D5, 4 cycles

Trial Locations (5)

Centre Hospitalier Robert Debré, Reims

Service d'Hématologie - Centre Hospitalier Lyon-Sud, Pierre-Bénite

Centre Henri Becquerel, Rouen

Groupe d'Etude des Lymphomes de l'Adulte, Yvoir

Institut Gustave Roussy, Villejuif